Promoter gets shares via preferential swap, stake dilutes to 6.39%

Ownership Changes View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.0%Next day

₹143.90

prior close

—

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-3.0%+3.0% vs market

Computers - Software & Consulting peers, median of 68sector-1.8%+1.8% vs sector

By the next day the stock moved 3.0 pts more than Nifty Microcap 250 and 1.8 pts more than its Computers - Software & Consulting peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

—-0.2—-0.5—

Next day

+0.0-3.0+3.0-1.8+1.8

—-2.7—-0.4—

—-1.9—-0.5—

+0.0-1.7+1.7+1.1-1.1

+0.0-1.0+1.0+1.2-1.2

+0.0-2.0+2.0+3.2-3.2

15d

—-6.6—-3.6—

—————

UpDownMarket · Nifty Microcap 250Sector · Computers - Software & Consulting peers, median of 68Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Promoter Nandkumar Kadam received 4,56,500 equity shares of iSera Lifesciences through a preferential share swap allotment on October 1, 2026. His absolute shareholding rose to 15,71,500 shares, but his stake diluted from 13.26% to 6.39% as total equity capital expanded from 84.09 lakh shares to 245.92 lakh shares. This is a regulatory disclosure under SAST Regulation 29(2).

Likely market impact

Promoter percentage holding fell sharply due to share swap, though absolute share count rose. No regulatory takeover threshold crossed.